Experimental treatment of bupivacaine cardiotoxicity: what is the best choice?
De La Coussaye, J.E.; Bassoul, B.P.; Gagnol, J.P.; Sassine, A.; Eledjam, J.J.
Regional Anesthesia 16(2): 120-122
1991
ISSN/ISBN: 0146-521X PMID: 2043529 Document Number: 367921
Document emailed within 1 workday
Related Documents
Hörnchen, U.; Fischer, M.; Lauven, P.M.; Hahn, N. 1993: The cardiotoxicity of bupivacaine during pacemaker stimulation is dependent on the stimulation frequency. Results of an experimental study Der Anaesthesist 42(6): 350-355Nolte, H. 1986: The problem of the cardiotoxicity of bupivacaine 0.75% Regional-Anaesthesie 9(3): 57-59
Wulf, H. 1991: Drug interactions in bupivacaine-induced cardiotoxicity Regional Anesthesia 16(2): 116-117
Girard, T.; Kern, C.; Hösli, I.; Heck, A.; Schneider, M.C. 2006: Ropivacaine versus bupivacaine 0.125% with fentanyl 1 microg/ml for epidural labour analgesia: is daily practice more important than pharmaceutical choice? Acta Anaesthesiologica Belgica 57(1): 45-49
Sánchez-Pereles, M.C.; Uribarri, F.J.; Gragera, I. 1993: 0.0625% bupivacaine compared with 0.125% bupivacaine continuously perfused epidurally during vaginal delivery Revista Espanola de Anestesiologia y Reanimacion 40(1): 9-11
Weindler, M.; Kossmann, B.; Dick, W.; Mehrkens, H.H.; Seeling, W.; Schwabe, K. 1984: Catheter peridural anesthesia with bupivacaine HCI and bupivacaine CO2. A comparison and the effects of premedication Regional-Anaesthesie 7(4): 125-130
Mazoit, J.X.; Boïco, O.; Samii, K. 1993: Myocardial uptake of bupivacaine: II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart Anesthesia and Analgesia 77(3): 477-482
Jörgensen, H. 1978: Epidural anesthesia with bupivacaine 0.75% in comparison with bupivacaine 0.5% and mepivacaine 1.5% with adrenaline Der Anaesthesist 27(1): Spec Sect: 11-15
Soen, S. 2007: First choice drug for treatment of osteoporosis and the strategic points for choice of drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 325-328
Gao, F.; Waters, B.; Seager, J.; Dowling, C.; Vickers, M.D. 1995: Comparison of bupivacaine plus buprenorphine with bupivacaine alone by caudal blockade for post-operative pain relief after hip and knee arthroplasty European Journal of Anaesthesiology 12(5): 471-476
Snoeck, M.M.J.; Vree, T.B.; Gielen, M.J.M.; Lagerwert, A.J. 2003: Steady state bupivacaine plasma concentrations and safety of a femoral "3-in-1" nerve block with bupivacaine in patients over 80 years of age International Journal of Clinical Pharmacology and Therapeutics 41(3): 107-113
Valairucha, S.; Maboonvanon, P.; Napachoti, T.; Sirivanasandha, B.; Suraseranuvongse, S. 2005: Cost-effectiveness of thoracic patient-controlled epidural analgesia using bupivacaine with fentanyl vs bupivacaine with morphine after thoracotomy and upper abdominal surgery Journal of the Medical Association of Thailand 88(7): 921-927
Niyogi, S.; Santra, S.; Chakraborty, J.; Chakraborty, S.; Mandal, S.; Mondal, C.R. 2011: A comparative study of duration of postoperative analgesia between epidural bupivacaine and epidural clonidine plus bupivacaine in lumbar laminectomy surgery under general anaesthesia Journal of the Indian Medical Association 109(4): 230-233
Pongraweewan, O.; Inchua, N.; Kitsiripant, C.; Kongmuang, B.; Tiwirach, W. 2016: Onset time of 2% Lidocaine and 0.5% Bupivacaine Mixture versus 0.5% Bupivacaine Alone using Ultrasound and Double Nerve Stimulation for Infraclavicular Brachial Plexus Anesthesia in ESRD Patients Undergoing Arteriovenous Fistula Creation Journal of the Medical Association of Thailand 99(5): 589-595
Pierce, L.J. 2001: Minimizing cardiotoxicity following breast radiotherapy: treatment planning is the key Cancer Journal 7(6): 477-479
Haque, M.M.; Aleem, M.A.; Haque, F.H.; Siddique, A.B.; Afrose, R. 2018: Efficacy of 0.5% Hyperbaric Bupivacaine with Dexamethasone versus 0.5% Hyperbaric Bupivacaine alone in Spinal Anaesthesia for Patient Undergoing Lower Abdominal Urological and Lower Limb Orthopedic Surgeries Mymensingh Medical Journal: Mmj 27(2): 375-381
Eberle, P. 1970: Chromosomal points of view in the choice of experimental objects Medizinische Monatsschrift 24(10): 448-453
Pal'chun, V.T.; Kriukov, A.I.; Podmazov, A.V.; Maksimenko, B.I. 1999: Experimental choice of drugs for pharmacophysical impact on larynx Vestnik Otorinolaringologii 4: 28-31
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Glybochko, P.V.; Nikolenko, V.N.; Fomkin, R.N.; Ponukalin, A.N.; Bliumberg, B.I. 2010: Clinico-experimental rationale of choice of optimal contact pneumatic ureterolithotripsy Urologiia 1: 56-60; Discussion: 60-61